Stocks and Investing Stocks and Investing
Thu, November 17, 2022
[ 12:00 AM ] - WOPRAI
Kelly Bania Downgraded (TGT) to Hold and Decreased Target to $165 on, Nov 17th, 2022
[ 12:00 AM ] - WOPRAI
Paul Trussell Downgraded (TGT) to Hold and Decreased Target to $144 on, Nov 17th, 2022
[ 12:00 AM ] - WOPRAI
Edward Yruma Upgraded (TGT) to Buy and Increased Target to $200 on, Nov 17th, 2022
[ 12:00 AM ] - WOPRAI
Paul Lejuez Maintained (TGT) at Strong Buy with Decreased Target to $177 on, Nov 17th, 2022
[ 12:00 AM ] - WOPRAI
Michael Lasser Maintained (TGT) at Strong Buy with Decreased Target to $194 on, Nov 17th, 2022
[ 12:00 AM ] - WOPRAI
Robert Moskow Maintained (TGT) at Buy with Decreased Target to $165 on, Nov 17th, 2022
[ 12:00 AM ] - WOPRAI
Steven Shemesh Maintained (TGT) at Buy with Decreased Target to $206 on, Nov 17th, 2022
[ 12:00 AM ] - WOPRAI
Simon Flannery Initiated (VTYX) at Buy and Held Target at $45 on, Nov 17th, 2022
[ 12:00 AM ] - WOPRAI
Jasper Hellweg Maintained (VRTX) at Strong Buy with Increased Target to $340 on, Nov 17th, 2022
[ 12:00 AM ] - WOPRAI
Rajat Gupta Upgraded (VRM) to Hold on, Nov 17th, 2022
[ 12:00 AM ] - WOPRAI
Brian McNamara Initiated (YETI) at Strong Buy and Held Target at $58 on, Nov 17th, 2022
[ 12:00 AM ] - WOPRAI
Paul Gong Upgraded (XPEV) to Strong Buy and Decreased Target to $13 on, Nov 17th, 2022
[ 12:00 AM ] - WOPRAI
Mark Massaro Maintained (XGN) at Strong Buy with Decreased Target to $7 on, Nov 17th, 2022
[ 12:00 AM ] - WOPRAI
Peter Benedict Maintained (TGT) at Buy with Decreased Target to $180 on, Nov 17th, 2022
[ 12:00 AM ] - WOPRAI
Christopher Horvers Maintained (TGT) at Buy with Decreased Target to $201 on, Nov 17th, 2022
[ 12:00 AM ] - WOPRAI
Bobby Griffin Maintained (TGT) at Strong Buy with Decreased Target to $185 on, Nov 17th, 2022
[ 12:00 AM ] - WOPRAI
Simeon Gutman Maintained (TGT) at Hold with Decreased Target to $155 on, Nov 17th, 2022
[ 12:00 AM ] - WOPRAI
Kate McShane Maintained (TGT) at Strong Buy with Decreased Target to $175 on, Nov 17th, 2022
[ 12:00 AM ] - WOPRAI
Scot Ciccarelli Maintained (TGT) at Hold with Decreased Target to $151 on, Nov 17th, 2022
[ 12:00 AM ] - WOPRAI
David Risinger Maintained (TBPH) at Buy with Increased Target to $14 on, Nov 17th, 2022
[ 12:00 AM ] - WOPRAI
Blayne Curtis Maintained (CRUS) at Buy with Decreased Target to $85 on, Nov 17th, 2022
[ 12:00 AM ] - WOPRAI
Nigel Dally Maintained (BHF) at Hold with Increased Target to $59 on, Nov 17th, 2022
[ 12:00 AM ] - WOPRAI
Mark Altschwager Maintained (BBWI) at Buy with Increased Target to $50 on, Nov 17th, 2022
[ 12:00 AM ] - WOPRAI
Ike Boruchow Maintained (BBWI) at Buy with Increased Target to $55 on, Nov 17th, 2022
[ 12:00 AM ] - WOPRAI
Arun Viswanathan Maintained (BERY) at Buy with Increased Target to $71 on, Nov 17th, 2022
[ 12:00 AM ] - WOPRAI
Tazeen Ahmad Downgraded (SRZN) to Sell and Decreased Target to $15 on, Nov 17th, 2022
[ 12:00 AM ] - WOPRAI
Ned Baramov Maintained (SPH) at Hold with Decreased Target to $17 on, Nov 17th, 2022
[ 12:00 AM ] - WOPRAI
Tim Moore Maintained (SPI) at Strong Buy with Decreased Target to $8 on, Nov 17th, 2022
[ 12:00 AM ] - WOPRAI
Rob Oliver Maintained (SPT) at Buy with Increased Target to $76 on, Nov 17th, 2022
[ 12:00 AM ] - WOPRAI
Hartaj Singh Maintained (SPRB) at Buy with Decreased Target to $8 on, Nov 17th, 2022

Hartaj Singh Maintained (SPRB) at Buy with Decreased Target to $8 on, Nov 17th, 2022


Published on 2024-10-28 00:14:04 - WOPRAI, Hartaj Singh
  Print publication without navigation


Hartaj Singh of Oppenheimer, Maintained "Spruce Biosciences, Inc." (SPRB) at Buy with Decreased Target from $13 to $8 on, Nov 17th, 2022.

Hartaj has made no other calls on SPRB in the last 4 months.



There is 1 other peer that has a rating on SPRB. Out of the 1 peers that are also analyzing SPRB, 0 agree with Hartaj's Rating of Hold.



This is the rating of the analyst that currently disagrees with Hartaj

  • Jonathan Wolleben of "JMP Securities" Initiated at Buy and Held Target at $8 on, Wednesday, November 16th, 2022
Contributing Sources